VCEL Vericel Corporation Stock Quote

VCEL [NASD]

Index	-	P/E	3566.25	EPS (ttm)	0.02	Insider Own	1.00%	Shs Outstand	45.55M	Perf Week	2.87%
Market Cap	2.72B	Forward P/E	122.45	EPS next Y	0.47	Insider Trans	-26.22%	Shs Float	44.89M	Perf Month	20.46%
Income	2.90M	PEG	-	EPS next Q	-0.04	Inst Own	-	Short Float	6.71%	Perf Quarter	52.57%
Sales	124.20M	P/S	21.93	EPS this Y	127.70%	Inst Trans	7.22%	Short Ratio	3.16	Perf Half Y	162.95%
Book/sh	2.95	P/B	19.34	EPS next Y	429.55%	ROA	1.70%	Target Price	58.71	Perf Year	399.21%
Cash/sh	1.59	P/C	35.93	EPS next 5Y	-	ROE	2.50%	52W Range	10.35 - 60.49	Perf YTD	84.78%
Dividend	-	P/FCF	181.56	EPS past 5Y	15.60%	ROI	1.60%	52W High	-5.67%	Beta	2.11
Dividend %	-	Quick Ratio	5.10	Sales past 5Y	19.40%	Gross Margin	67.80%	52W Low	451.30%	ATR	3.70
Employees	273	Current Ratio	5.50	Sales Q/Q	14.70%	Oper. Margin	1.90%	RSI (14)	58.23	Volatility	7.11% 7.21%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	7.10%	Profit Margin	2.30%	Rel Volume	0.34	Prev Close	56.60
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 24 BMO	Payout	0.00%	Avg Volume	952.00K	Price	57.06
Recom	1.70	SMA20	5.13%	SMA50	14.46%	SMA200	95.61%	Volume	325,294	Change	0.81%

Jan-11-21

Downgrade

Oppenheimer

Outperform → Perform

Dec-18-20

Initiated

Stephens

Overweight

$31

Sep-17-20

Initiated

Truist

Buy

$24

Oct-09-19

Initiated

H.C. Wainwright

Buy

$19

Feb-28-19

Downgrade

Needham

Buy → Hold

Aug-08-18

Reiterated

Needham

Buy

$15 → $14

Jul-16-18

Upgrade

Ladenburg Thalmann

Neutral → Buy

Apr-04-18

Initiated

Leerink Partners

Outperform

$15

Mar-06-18

Reiterated

Needham

Buy

$5 → $15

Mar-06-18

Downgrade

Ladenburg Thalmann

Buy → Neutral

Mar-05-18

Reiterated

BTIG Research

Buy

$8 → $13

Jun-21-17

Initiated

BTIG Research

Buy

Mar-13-17

Reiterated

Needham

Buy

$9 → $6

Dec-22-16

Initiated

Piper Jaffray

Overweight

Nov-09-16

Reiterated

Needham

Buy

$12 → $9

Apr-05-16

Downgrade

BofA/Merrill

Buy → Neutral

Mar-11-16

Upgrade

Needham

Hold → Buy

$12

Apr-09-21 09:24AM	Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 GlobeNewswire
Mar-18-21 05:40PM	Why Vericel Stock Raced 13% Higher on Thursday Motley Fool +13.45%
08:16AM	The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga
Mar-17-21 06:00PM	Vericel Set to Join S&P SmallCap 600 PR Newswire
Mar-10-21 05:50PM	Vericel Corporation (VCEL) Stock Sinks As Market Gains: What You Should Know Zacks
08:30AM	Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 GlobeNewswire
Mar-08-21 07:43AM	Vericel Corporation's (NASDAQ:VCEL) Stock Is Going Strong: Have Financials A Role To Play? Simply Wall St.
Mar-04-21 06:33AM	2 Overvalued Biotech Stocks Still Worth Buying Motley Fool
Mar-02-21 08:30AM	Vericel Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Life Sciences Conference GlobeNewswire
Feb-24-21 02:01PM	Vericel (VCEL) Q4 2020 Earnings Call Transcript Motley Fool
08:50AM	Recap: Vericel Q4 Earnings Benzinga
08:00AM	Vericel Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Full-Year 2021 Financial Guidance GlobeNewswire
06:30AM	Vericel Corp. to Host Earnings Call ACCESSWIRE
Feb-22-21 08:30AM	Vericel to Present at the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 GlobeNewswire -5.76%
Feb-16-21 08:30AM	Vericel to Participate in the BTIG Virtual MedTech Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021 GlobeNewswire
Feb-12-21 08:30AM	Vericel Announces Termination of Shareholder Rights Agreement GlobeNewswire
Feb-10-21 08:00AM	Vericel to Report Fourth-Quarter 2020 Financial Results on February 24, 2021 GlobeNewswire
Feb-04-21 12:00PM	Vericel Corporation (VCEL) Moves to Strong Buy: Rationale Behind the Upgrade Zacks
Feb-01-21 09:42AM	Vericel, Intuit, Mosaic, Ally Financial and D.R. Horton highlighted as Zacks Bull and Bear of the Day Zacks +7.51%
05:20AM	Bull of the Day: Vericel (VCEL) Zacks
Jan-25-21 08:30AM	Vericel Announces Appointment of Joe Mara as Chief Financial Officer GlobeNewswire +5.82%
Jan-11-21 07:15AM	Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates GlobeNewswire
Jan-08-21 08:30AM	Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021 GlobeNewswire
Jan-07-21 08:30AM	Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee GlobeNewswire +10.58%
07:05AM	Zacks Market Edge Highlights: Vericel, Tesla, Chewy, Alibaba and Facebook Zacks
Jan-06-21 12:48PM	Should You Sell Your Big Winner Stocks? Zacks
Dec-19-20 10:10PM	Is VCEL A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-18-20 08:30AM	Vericel to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 GlobeNewswire
Nov-09-20 11:44AM	Vericel Corporation Just Reported A Surprise Profit And Analysts Updated Their Estimates Simply Wall St. +7.56%
Nov-05-20 10:32PM	Vericel (VCEL) Q3 2020 Earnings Call Transcript Motley Fool
08:00AM	Vericel Reports Record Third Quarter Revenues and Net Income GlobeNewswire
Nov-03-20 09:43AM	Vericel Corp, Nikola Corp, Lowe's, Dollar General and Best Buy highlighted as Zacks Bull and Bear of the Day Zacks +9.64%
05:54AM	Bull of the Day: Vericel (VCEL) Zacks
Nov-02-20 08:30AM	Vericel to Present at Upcoming Investor Conferences GlobeNewswire
06:40AM	Vericel Corp (VCEL) Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-30-20 03:54PM	Alkermes (ALKS) Beats on Q3 Earnings & Sales, Lifts Guidance Zacks
Oct-29-20 11:30AM	Alexion (ALXN) Beats on Q3 Earnings & Sales, Ups '20 Guidance Zacks
11:24AM	Dr. Reddy's (RDY) Q2 Earnings Decline Y/Y, Sales Increase Zacks
Oct-22-20 08:30AM	Vericel to Report Third-Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire
Oct-14-20 08:00AM	Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million GlobeNewswire
Oct-12-20 10:35AM	P/E Ratio Insights for Vericel Benzinga
Oct-09-20 08:30AM	Vericel To Host Virtual Analyst and Investor Day on October 16, 2020 GlobeNewswire
Sep-16-20 07:30AM	Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire
07:30AM	MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire
Sep-09-20 08:30AM	Vericel to Present at Multiple Upcoming Investor Conferences GlobeNewswire
Sep-04-20 08:30AM	Vericel to Present at the 18th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020 GlobeNewswire
Aug-25-20 08:25AM	Did You Miss Vericel's (NASDAQ:VCEL) Whopping 413% Share Price Gain? Simply Wall St.
07:00AM	MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness GlobeNewswire
Aug-10-20 09:19AM	Did Hedge Funds Make The Right Call On Vericel Corp (VCEL)? Insider Monkey
Aug-05-20 08:00AM	Vericel Reports Second Quarter 2020 Financial Results GlobeNewswire -5.35%
Jul-22-20 08:30AM	Vericel to Report Second-Quarter 2020 Financial Results on August 5, 2020 GlobeNewswire
Jul-15-20 08:33AM	Do Options Traders Know Something About Vericel (VCEL) Stock We Don't? Zacks
Jul-09-20 08:30AM	Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates GlobeNewswire
Jun-30-20 07:00AM	Vericel Announces Submission of Biologics License Application to the FDA for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire
07:00AM	MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns GlobeNewswire
Jun-23-20 01:48PM	Hedge Funds Are Selling Vericel Corp (VCEL) Insider Monkey
May-28-20 03:38AM	Edited Transcript of VCEL earnings conference call or presentation 5-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-27-20 11:14AM	Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories Zacks
May-26-20 09:27AM	Dump These 4 Toxic Stocks or Sell Short for Timely Profits Zacks
May-13-20 08:30AM	Vericel to Present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020 GlobeNewswire
May-06-20 12:02AM	Vericel (VCEL) Q1 2020 Earnings Call Transcript Motley Fool
May-05-20 09:34AM	Recap: Vericel Q1 Earnings Benzinga
08:00AM	Vericel Reports First Quarter 2020 Financial Results GlobeNewswire
Apr-22-20 08:30AM	Vericel to Report First-Quarter 2020 Financial Results on May 5, 2020 GlobeNewswire
Apr-10-20 09:00AM	Vericel Announces Change to a Virtual Meeting Format For 2020 Annual Meeting of Shareholders GlobeNewswire
Apr-08-20 08:30AM	Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020 GlobeNewswire +11.23%
Apr-02-20 02:58PM	Boston Scientific cuts exec pay as revenue slides American City Business Journals
09:00AM	Vericel Provides Business and Financial Updates GlobeNewswire
Mar-31-20 09:39AM	We're Excited To See How Vericel (NASDAQ:VCEL) Uses Its Cash Hoard To Grow Simply Wall St.
Mar-10-20 03:17AM	Edited Transcript of VCEL earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
Mar-04-20 08:29AM	Zacks.com featured highlights include: Envestnet, First Majestic Silver, Myriad Genetics, Vericel and Casella Waste Systems Zacks
Mar-03-20 09:28AM	Dump These 5 Toxic Stocks Right Away Zacks
Feb-25-20 08:00AM	Vericel Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Full-Year 2020 Financial Guidance GlobeNewswire -11.65%
06:15AM	Vericel Corp. to Host Earnings Call ACCESSWIRE
Feb-24-20 10:04AM	Vericel to Present at the 40th Annual Cowen Healthcare Conference on Monday, March 2, 2020 GlobeNewswire
09:05AM	Should You Buy Vericel (VCEL) Ahead of Earnings? Zacks
09:02AM	Cronos (CRON) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-19-20 08:00AM	Vericel to Present at the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 GlobeNewswire
Feb-14-20 09:49AM	Will Vericel Continue to Surge Higher? Zacks
Feb-13-20 08:48AM	The Zacks Analyst Blog Highlights: MarineMax, Metropolitan Bank, Earthstone Energy, Rite Aid and Vericel Zacks
08:44AM	The Zacks Analyst Blog Highlights: Accuray, MagnaChip Semiconductor, Rite Aid, Vericel and RGC Resources Zacks
Feb-12-20 08:06AM	Small Business Optimism Rises Amid Coronavirus Fears: 5 Picks Zacks
07:38AM	Virus or No Virus, Investing Case in US Stocks Looks Solid! Zacks
Feb-11-20 08:00AM	Vericel to Report Fourth-Quarter 2019 Financial Results on February 25, 2020 GlobeNewswire
Feb-10-20 10:20AM	What's in Store for Acorda (ACOR) This Earnings Season? Zacks
Jan-31-20 12:46PM	An Intrinsic Calculation For Vericel Corporation (NASDAQ:VCEL) Suggests It's 49% Undervalued Simply Wall St.
Jan-09-20 08:00AM	Vericel to Present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020 GlobeNewswire
Jan-06-20 06:30AM	BARDA Initiates the Procurement of NexoBrid for Emergency Response GlobeNewswire
Dec-19-19 07:07AM	Vericel Sees Hammer Chart Pattern: Time to Buy? Zacks
Dec-17-19 02:46PM	Vericel's (NASDAQ:VCEL) Wonderful 504% Share Price Increase Shows How Capitalism Can Build Wealth Simply Wall St.
Dec-11-19 09:48AM	Is Vericel Corp (VCEL) A Good Stock To Buy? Insider Monkey
Dec-06-19 07:20AM	Edited Transcript of VCEL earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-06-19 10:55AM	Stock Market News for Nov 6, 2019 Zacks
09:00AM	Vericel Announces Appointment of Sean C. Flynn as Vice President and General Counsel GlobeNewswire
Nov-05-19 08:00AM	Vericel Reports Record Third Quarter Revenues, Net Income and Operating Cash Flow GlobeNewswire +12.86%
Oct-31-19 03:43PM	How Much is Vericel Corporation's (NASDAQ:VCEL) CEO Getting Paid? Simply Wall St.
Oct-28-19 08:18PM	Is Vericel Corp (VCEL) Going To Burn These Hedge Funds ? Insider Monkey
Oct-22-19 08:30AM	Vericel to Report Third-Quarter 2019 Financial Results on November 5, 2019 GlobeNewswire
Oct-09-19 03:09PM	Vericel Analyst Projects Wound Care Product Sales Will Grow Fivefold By 2025 Benzinga
Oct-02-19 07:30AM	Vericel and MediWound Announce Initiation of U.S. NexoBrid Expanded Access Treatment Protocol GlobeNewswire

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Colangelo Dominick	President and CEO	Mar 30	Option Exercise	25.80	7,500	193,500	175,050	Mar 30 04:50 PM
Hopper Jonathan Mark	Chief Medical Officer	Mar 30	Option Exercise	10.95	33,438	366,146	49,584	Mar 31 04:17 PM
Hopper Jonathan Mark	Chief Medical Officer	Mar 30	Sale	51.40	17,924	921,270	22,966	Mar 31 04:17 PM
Colangelo Dominick	President and CEO	Mar 29	Sale	51.01	40,000	2,040,254	167,550	Mar 30 04:50 PM
Rubino Alan L	Director	Mar 19	Option Exercise	45.20	5,000	226,000	7,644	Mar 22 04:19 PM
Colangelo Dominick	President and CEO	Mar 01	Option Exercise	3.80	28,355	107,696	243,742	Mar 02 04:15 PM
Colangelo Dominick	President and CEO	Mar 01	Sale	48.11	40,000	1,924,227	207,550	Mar 02 04:15 PM
Hopper Jonathan Mark	Chief Medical Officer	Feb 11	Option Exercise	0.00	1,625	0	25,371	Feb 12 04:17 PM
Colangelo Dominick	President and CEO	Feb 11	Option Exercise	0.00	7,500	0	222,462	Feb 12 04:16 PM
Halpin Michael	Chief Operating Officer	Feb 11	Option Exercise	0.00	3,500	0	6,953	Feb 12 04:12 PM
Halpin Michael	Chief Operating Officer	Feb 06	Option Exercise	0.00	1,875	0	4,345	Feb 08 04:26 PM
Hopper Jonathan Mark	Chief Medical Officer	Feb 06	Option Exercise	0.00	650	0	24,010	Feb 08 04:25 PM
Colangelo Dominick	President and CEO	Feb 06	Option Exercise	0.00	6,938	0	218,040	Feb 08 04:24 PM
Halpin Michael	Chief Operating Officer	Dec 21	Option Exercise	2.65	30,000	79,500	32,279	Dec 23 04:10 PM
Hopper Jonathan Mark	Chief Medical Officer	Dec 21	Option Exercise	10.95	43,264	473,741	35,069	Dec 23 04:11 PM
Hopper Jonathan Mark	Chief Medical Officer	Dec 21	Sale	26.54	24,235	643,159	4,331	Dec 23 04:11 PM
Halpin Michael	Chief Operating Officer	Dec 21	Sale	26.28	30,000	788,400	2,279	Dec 23 04:10 PM
ZERBE ROBERT L MD	Director	Nov 23	Option Exercise	3.25	30,000	97,500	49,295	Nov 24 04:09 PM
ZERBE ROBERT L MD	Director	Nov 23	Sale	23.55	17,500	412,125	31,795	Nov 24 04:09 PM
Halpin Michael	Chief Operating Officer	Jun 23	Option Exercise	7.20	14,751	106,207	16,373	Jun 24 04:19 PM
Halpin Michael	Chief Operating Officer	Jun 23	Sale	15.01	14,751	221,413	1,622	Jun 24 04:19 PM
Halpin Michael	Chief Operating Officer	Jun 16	Option Exercise	2.65	2,890	7,658	5,624	Jun 18 04:03 PM
Halpin Michael	Chief Operating Officer	Jun 16	Sale	15.00	4,002	60,030	1,622	Jun 18 04:03 PM
Colangelo Dominick	President and CEO	May 08	Option Exercise	2.75	13,125	36,094	210,492	May 08 04:09 PM
ZERBE ROBERT L MD	Director	Apr 29	Option Exercise	0.00	1,750	0	19,295	May 01 04:17 PM
GILMAN STEVEN C	Director	Apr 29	Option Exercise	0.00	1,750	0	1,750	May 01 04:15 PM
Hagen Heidi	Director	Apr 29	Option Exercise	0.00	1,750	0	1,750	May 01 04:14 PM
MCLAUGHLIN KEVIN F	Director	Apr 29	Option Exercise	0.00	1,750	0	1,750	May 01 04:13 PM
Wotton Paul K	Director	Apr 29	Option Exercise	0.00	1,750	0	1,750	May 01 04:12 PM
Rubino Alan L	Director	Apr 29	Option Exercise	0.00	1,750	0	2,644	May 01 04:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience